Avansya, the joint venture between Cargill and Royal DSM, has started production at the first commercial-scale fermentation facility for stevia sweeteners in the United States. The facility is producing EverSweet, a non-artificial, zero-calorie stevia sweetener.
The $50 million fermentation facility is in Blair, Neb., and is operated by Cargill. The 10,000-square-foot facility took approximately 225,000 hours to build and features six miles of new piping and 2,000 new instruments, in addition to the fermenters and evaporators that were installed.
“Building this first-of-its-kind, stevia sweetener fermentation facility on the existing Cargill Blair campus reaffirms our pledge to helping food and beverage manufacturers meet the sharply rising consumer demand for great-tasting, zero-calorie products to meet their dietary needs and goals,” said Mike Wagner, Cargill managing director and chairman of the board of Avansya. “It also reaffirms our commitment to strengthening the business community and Nebraska as a biotechnology mecca.”
EverSweet is GRAS and FEMA GRAS approved for use in food and beverage products in the United States and Mexico and additional regulatory approvals for use in other countries are underway.
Short-term increases in sugar consumption could increase the risk of inflammatory bowel disease and have a significant impact on our health, a new study out of the University of Alberta (U of A) suggests.
Avansya, the joint venture between Cargill and Royal DSM, has started production at the first commercial-scale fermentation facility for stevia sweeteners in the United States.
Sugar reduction remains a central topic in the media and among consumers and opportunities for reducing sugar intake are taking several directions as companies address evolving concerns and demands.
Stevia-based sweetener company SweeGen has announced that the European Food Safety Authority (EFSA) food additive and flavoring panel found no safety concerns for its bioconverted rebaudioside M (reb M) stevia leaf sweetener.
A new American Academy of Pediatrics (AAP) policy statement offers a summary of the existing data around nonnutritive sweeteners and recommends future research into how they affect children’s weight, taste preferences, the risk for diabetes, and long-term safety.